Product update
A thoughtful goodbye to Speakprose.
Cognixion is retiring Speakprose 3 and Speakprose Unlimited.
Speakprose has helped people express needs, ideas, humor, and connection in their own words. We know an AAC product can be far more than software. For some people, it is part of how they are heard. This transition deserves clarity, time, and human support.
Why we made this decision
One focus. A more capable path forward.
We are concentrating our resources on the clinical and regulatory development of Cognixion ONE—our next-generation, noninvasive communication platform—and the work required to pursue authorization from the FDA.
Cognixion ONE has received FDA Breakthrough Device designation. That designation supports more timely FDA interaction and review; it is not FDA clearance or approval, and Cognixion ONE is not currently available as a replacement for Speakprose.
What happens next
A transition built around continuity.
These dates reflect our current transition plan. App Store purchase and subscription terms still apply, and we will communicate any account-specific changes directly.
-
Now
Plan with us
Contact our team for account-specific guidance, questions about access, or help planning a communication backup before any service changes.
-
New sales end
We plan to remove Speakprose products and new subscriptions from sale. Existing customers will continue to receive transition communications and support.
-
Connected services transition
This is our current target for ending Speakprose connected services. We will provide more detailed account and continuity guidance before that date.
If Speakprose is part of your daily communication, involve the person who communicates, their family or support team, and their speech-language or assistive-technology professional. Our customer care team is here to help with product-specific questions.
Email customercare@cognixion.com
The work ahead
Help shape what comes next.
People interested in future Cognixion research can register their interest with our clinical team. Study availability and eligibility vary, and submitting the form does not guarantee participation.
Clinical research is not a replacement communication service. The government study record is provided for transparency and may be updated by the study sponsor and the National Library of Medicine.
Built with community
Join the Brainiac Community.
Our community of users, families, clinicians and advocates shapes what we build and gets early access to new technology before anyone else. This is where the next chapter starts.
Join the Brainiac CommunityQuestions, answered
We will help you navigate the change.
What happens to my subscription or purchase?
Your App Store purchase and subscription terms continue to apply. You can review or manage an active subscription in your Apple Account settings. Contact us for account-specific guidance.
Can I move directly to Axon-R?
No. Axon-R is a research-use device and is not currently available as a Speakprose replacement. Please make a separate continuity plan for communication.
Can I join a Cognixion study?
You can register your interest with our clinical team. Participation depends on an available study, its eligibility requirements, and review by the study team.
Where can I get help?
Email customercare@cognixion.com. Tell us which Speakprose product you use and the kind of help you need so we can route your request.
To the Speakprose community
Thank you for trusting us with your words.
We are grateful to every communicator, family member, clinician, educator, and advocate who challenged us to build better. We will carry what you taught us into the work ahead.
Talk with our team